ClinicalTrials.gg
Active, not recruitingNCT05889364Updated Jun 5, 2023

AI-based System for Lung Tuberculosis Screening: Diagnostic Accuracy Evaluation

An observational study in Tuberculosis, Pulmonary, sponsored by Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department. Active, not recruiting at 1 site in Russian Federation. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-06-05.

Sponsored by Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
308
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Testing of AI solutions to assess diagnostic accuracy for tuberculosis detection.

Read the detailed description

Tuberculosis remains a key problem of modern medicine. New approaches for burden overcoming should be proposed. New screening strategies may include artificial intelligence (AI). An AI-based system for chest x-ray analysis and triage ("normal/tuberculosis suspected") have been developed and trained. A special data-set was prepared. There are 238 normal x-rays and 70 x-rays with lung tuberculosis in data-set. The data-set was randomly divided into 2 samples:

  • sample N1 (n=140) with ratio "normal: tuberculosis" 50:50,
  • sample N1 (n=150) with ratio "normal: tuberculosis" 95:5. Both samples will be analysed by AI-based system. Results will be quantified using diagnostic accuracy metrics: sensitivity and specificity, positive and negative predictor values, likelihood ratio, and area under the ROC (receiver operating characteristic) curve.
02

Conditions studied

  • Tuberculosis, Pulmonary

Keywords

  • AI
  • deep learning
  • tuberculosis
  • radiology
  • x-ray
  • e-health
  • screening
  • chest
  • artificial intelligence
03

In context

Tuberculosis, Pulmonary

320 studies on the registry are indexed under Tuberculosis, Pulmonary; 72 are open to participants now.

This study's enrollment of 308 is close to the median of 300 across 83 observational studies indexed under Tuberculosis, Pulmonary.

Browse Tuberculosis, Pulmonary studies →

Lead sponsor

Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department is the lead sponsor of 11 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

308 chest x-ray images selected from the database of Unified Radiological Information Service (URIS) of Moscow

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • no pathology in a lung on chest x-ray
  • signs of lung tuberculosis on chest x-ray

Exclusion criteria

Exclusion Criteria:

  • any pathology in the lungs (except tuberculosis)
05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
308 participants (actual)
Patient registry
No

Groups and cohorts

  • Sample N1

    (n=140) with ratio "normal: tuberculosis" 50:50

    Diagnostic Test: AI-based x-ray analysis and triage ("normal/tuberculosis suspected")

  • Sample N2

    (n=150) with ratio "normal: tuberculosis" 95:5

    Diagnostic Test: AI-based x-ray analysis and triage ("normal/tuberculosis suspected")

Interventions

  • Diagnostic testAI-based x-ray analysis and triage ("normal/tuberculosis suspected")

    All included x-rays will be analysed by the AI-based system. Then results will be compared with opinions of 2 experienced radiologists (they make peer-review of all included images independently of each other).

    Also known as: artificial intelligence analysis of medical images

06

What researchers measure

Primary outcomes

  1. Diagnostic accuracy metric 1

    Sensitivity

    Time frame: Day 1 upon receipt of data

  2. Diagnostic accuracy metric 2

    Specificity

    Time frame: Day 2 upon receipt of data

  3. Diagnostic accuracy metric 3

    Positive predictor values

    Time frame: Day 3 upon receipt of data

  4. Diagnostic accuracy metric 4

    Negative predictor values

    Time frame: Day 4 upon receipt of data

  5. Diagnostic accuracy metric 5

    Likelihood ratio

    Time frame: Day 5 upon receipt of data

  6. Diagnostic accuracy metric 6

    Area under the ROC curve

    Time frame: Day 6 upon receipt of data

07

Study locations

1 site
  • Research and Practical Center of Medical Radiology, Department of Health Care of Moscow
    Moscow, 109029, Russian Federation
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2018 to primary completion in Mar 2018, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 28, 2018
First posted
Jun 5, 2023
StartActual
Feb 1, 2018
Primary completionActual
Mar 15, 2018
CompletionEst.
Dec 30, 2023
Last update
Jun 5, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05889364
Lead sponsor
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
Responsible party
Anton V. Vladzymyrskyy (Deputy CEO, Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department) — Principal investigator
First posted
Jun 5, 2023
Start date
Feb 1, 2018
Primary completion
Mar 15, 2018
Completion
Dec 30, 2023 (estimated)
Last update
Jun 5, 2023

Study contacts

Anton Vladzymyrskyy
principal investigator · Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion